Philogen Statistics

Total Valuation

Philogen has a market cap or net worth of EUR 951.84 million. The enterprise value is 863.31 million.

Market Cap	951.84M
Enterprise Value	863.31M

Important Dates

The last earnings date was Tuesday, September 23, 2025.

Earnings Date	Sep 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Philogen has 40.33 million shares outstanding. The number of shares has increased by 1.47% in one year.

Current Share Class	28.96M
Shares Outstanding	40.33M
Shares Change (YoY)	+1.47%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	4.40%
Float	n/a

Valuation Ratios

The trailing PE ratio is 20.91 and the forward PE ratio is 2.59.

PE Ratio	20.91
Forward PE	2.59
PS Ratio	11.24
PB Ratio	7.57
P/TBV Ratio	7.64
P/FCF Ratio	25.62
P/OCF Ratio	24.07
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.09, with an EV/FCF ratio of 23.24.

EV / Earnings	18.80
EV / Sales	10.20
EV / EBITDA	20.09
EV / EBIT	22.19
EV / FCF	23.24

Financial Position

The company has a current ratio of 5.73, with a Debt / Equity ratio of 0.09.

Current Ratio	5.73
Quick Ratio	5.45
Debt / Equity	0.09
Debt / EBITDA	0.27
Debt / FCF	0.31
Interest Coverage	33.81

Financial Efficiency

Return on equity (ROE) is 45.54% and return on invested capital (ROIC) is 21.42%.

Return on Equity (ROE)	45.54%
Return on Assets (ROA)	18.42%
Return on Invested Capital (ROIC)	21.42%
Return on Capital Employed (ROCE)	28.08%
Revenue Per Employee	462,639
Profits Per Employee	250,896
Employee Count	183
Asset Turnover	0.64
Inventory Turnover	6.81

Taxes

Income Tax	-5.39M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.00% in the last 52 weeks. The beta is 0.15, so Philogen's price volatility has been lower than the market average.

Beta (5Y)	0.15
52-Week Price Change	+18.00%
50-Day Moving Average	22.71
200-Day Moving Average	21.06
Relative Strength Index (RSI)	59.69
Average Volume (20 Days)	15,567

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Philogen had revenue of EUR 84.66 million and earned 45.91 million in profits. Earnings per share was 1.13.

Revenue	84.66M
Gross Profit	60.02M
Operating Income	38.91M
Pretax Income	40.53M
Net Income	45.91M
EBITDA	41.96M
EBIT	38.91M
Earnings Per Share (EPS)	1.13

Full Income Statement

Balance Sheet

The company has 100.02 million in cash and 11.50 million in debt, giving a net cash position of 88.53 million or 2.19 per share.

Cash & Cash Equivalents	100.02M
Total Debt	11.50M
Net Cash	88.53M
Net Cash Per Share	2.19
Equity (Book Value)	125.81M
Book Value Per Share	3.13
Working Capital	98.10M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 39.55 million and capital expenditures -2.40 million, giving a free cash flow of 37.15 million.

Operating Cash Flow	39.55M
Capital Expenditures	-2.40M
Free Cash Flow	37.15M
FCF Per Share	0.92

Full Cash Flow Statement

Margins

Gross margin is 70.90%, with operating and profit margins of 45.96% and 54.23%.

Gross Margin	70.90%
Operating Margin	45.96%
Pretax Margin	47.87%
Profit Margin	54.23%
EBITDA Margin	49.56%
EBIT Margin	45.96%
FCF Margin	43.87%

Dividends & Yields

Philogen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.47%
Shareholder Yield	n/a
Earnings Yield	4.82%
FCF Yield	3.90%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6